ArticleBMC public health2026
Network analysis of intimate partner violence and depression-anxiety symptoms in Chinese transgender women.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundChinese transgender women have a higher prevalence of intimate partner violence (IPV) compared to their cisgender counterparts. To mitigate the risk of IPV, it is crucial to comprehend the symptoms of emotional distress that are most closely associated with IPV. This network analysis investigated the item-level connections among depressive symptoms, anxiety symptoms, and IPV among Chinese transgender women.
methodsBetween February and December 2022, 264 adult transgender women in Shenyang, China, were recruited through snowball sampling with support from a community-based non-governmental organization. Data were collected using the Intimate Partner Violence Scale, the Patient Health Questionnaire (PHQ-9), and the Generalized Anxiety Disorder Questionnaire (GAD-7). The network structure of depressive symptoms, anxiety symptoms, and IPV was examined using "Expected Influence" and "Bridge Expected Influence" as measures of centrality. The stability of the network was assessed through a case-dropping bootstrap approach. A Network Comparison Test was conducted to examine whether network characteristics differed based on the presence or absence of IPV.
resultsAmong 264 participants, 221 (83.7%) reported having experienced IPV. The most central symptom was PHQ6 (guilt), followed by GAD2 (uncontrollable worry) and GAD1 (nervousness). The bridge symptoms linking the depression and anxiety communities were GAD2 (uncontrollable worry), PHQ9 (suicide), and GAD5 (restlessness). A flow network indicated that the strongest associations between IPV and depressive and anxiety symptoms were for GAD5 (restlessness) and PHQ2 (sad mood). Network Comparison Test revealed no significant differences in global strength or structure between the IPV and non-IPV groups.
conclusionsFindings highlight specific depressive and anxiety symptoms as key correlates of IPV among Chinese transgender women. These central and bridge symptoms offer hypothesis-generating entry points for future longitudinal research and may inform the development of targeted interventions; however, the cross-sectional design precludes causal or directional conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.